(Q83078390)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195321%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Should anthracyclines and dexrazoxane be used for children with cancer? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195321%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

Elvira C van Dalen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195321%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

5

Leontien C Kremer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195321%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

4

Huib N Caron

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195321%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Henk van den Berg

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195321%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Martine F Raphaël

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195321%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195321%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195321%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195321%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195321%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

12-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195321%20AND%20SRC:MED&resulttype=core&format=json

Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970301-6

7 January 2021

Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970301-6

7 January 2021

Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970301-6

7 January 2021

The treatment of stages I-IV favorable histology Wilms' tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970301-6

7 January 2021

Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970301-6

7 January 2021

Cardioprotective interventions for cancer patients receiving anthracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970301-6

7 January 2021

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970301-6

7 January 2021

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970301-6

7 January 2021

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970301-6

7 January 2021

Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970301-6

7 January 2021

Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970301-6

7 January 2021

10.1016/S1470-2045(10)70301-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21195321%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference